Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Certain Dibenzo derivatives may help treat prostate cancer.

Some dibenzo compounds might help treat cancer with fewer side effects.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Bicalutamide shows promise for treating female hair loss.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Oral bicalutamide is safe and effective for female hair loss.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Certain drugs that block specific enzymes can help treat prostate diseases.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.